Overview

Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to assess the potential therapeutic effect of N-acetylcysteine "NAC" in COVID 19 patients.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ain Shams University
Collaborator:
Misr International University
Treatments:
Acetylcysteine
N-monoacetylcystine
Criteria
Inclusion Criteria:

1. Adults aged more than 18 years

2. Documented COVID-19 infection (either performed on site or documented external
report), only moderate cases will be included

Exclusion Criteria:

1. Known allergy or hypersensitivity to NAC

2. Pregnancy

3. Critically ill or mechanically ventilated patients